로딩 중…
StockDiggingStockDigging

Quest Diagnostics Incorporated

DGX· NYSE
$194.96-1.42%
2026-06-18

Price Chart

Quest Diagnostics Incorporated+9.92%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$21.58B
Revenue$11.28B
Net Income$1.02B
Total Assets$16.67B
Net Assets$7.37B
Employees46,000
Value
P/E21.08x
P/B2.93x
PEG1.45x
P/S1.91x
EV/EBITDA14.23x
FCF Yield6.14%
Profitability
ROE13.90%
ROA6.14%
Op. Margin14.31%
Revenue Growth9.16%
Earnings Growth14.55%
Financial Health
Debt Ratio122.28%
Total Debt$6.98B
FCF$1.33B
Cash$393M
Current Ratio1.18x
Net Debt/EBITDA3.33x
Dividend
Div. Yield1.65%
Div. Growth6.65%
Performance
1Y Return9.92%
1M Return2.40%
From 52W High-8.68%
1Y MDD-11.94%
Trading
Volume622,003 shares
Trading Value$121M
Per Share
EPS$8.94
BPS$64.59

Company Info

CEO Mr. James E. Davis
Employees 46,000
HQ Secaucus, United States

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.